Press Releases

 
Press Releases
  Date Title View
Mar 3, 2011
Full Year System Placements More Than Double to 82 CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK) today reported financial results for the fourth quarter and year ended December 31, 2010. Fourth Quarter 2010 Results: Reven...
PDF
Mar 1, 2011
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics Inc. (NASDAQ:GNMK) announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned ...
PDF
Feb 24, 2011
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that Life Technologies Corporation and Applied Biosystems LLC dismissed their patent infringement lawsuit against GenMark filed November 19, 2010 in the Southern District of California. The suit alleged that GenMark ...
PDF
Feb 22, 2011
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its fourth quarter and fiscal year 2010 earnings results following the close of market on Thursday, March 3, 2011. Management will hold a conference call to review the company's fourth quarter and ...
PDF
Nov 24, 2010
CARLSBAD, Calif., Nov. 24, 2010 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a provider of automated, multiplex molecular diagnostic testing systems, announced today that its Chairman and CEO, Christopher Gleeson, will be presenting an update on the company's progress at the Piper Jaffray 22nd Annual Health Care Conference held at t...
PDF
Nov 4, 2010
Reagent Revenues Increase 164% over Prior YearSystem Placements Increase by Thirteen to Thirty-Three Year-to-Date CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK) today reported revenues of $667,000 for the quarter ending September 30, 2010, a 162% increase ...
PDF
Nov 2, 2010
CARLSBAD, Calif., Nov 02, 2010 (BUSINESS WIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States. The ...
PDF
Oct 18, 2010
CARLSBAD, Calif., Oct 18, 2010 (BUSINESS WIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter 2010 financial results after market close on Thursday, November 4, 2010. Management will hold a conference call to review the company's third quarter 2010 performance starting a...
PDF
Oct 1, 2010
CARLSBAD, Calif., Oct 1, 2010 (GlobeNewswire via COMTEX News Network) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a provider of automated, multiplex molecular diagnostic testing systems, announced today that it will be presenting an update on the company's progress at the William Blair Emerging Growth Stock Conference at the Intercontinental New Yo...
PDF
Sep 27, 2010
CARLSBAD, Calif., Sep 27, 2010 (BUSINESS WIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor(R) Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study; the WARFARIN Trial (Wa...
PDF
FirstPrevious
...
12
NextLast